Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    INFLAMMATORY BOWEL DISEASE 16
Show Display Options
Rank Status Study
1 Recruiting One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Rifaximin DR;   Drug: Placebo
2 Recruiting One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Rifaximin DR;   Drug: Placebo

Indicates status has not been verified in more than two years